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Abstract
Background:  To measure the prevalence of and associations among impairments, activity
limitations and participation restrictions in persons living with HIV in British Columbia to inform
support and care programs, policy and research.
Methods:  A cross-sectional population-based sample of persons living with HIV in British
Columbia was obtained through an anonymous survey sent to members of the British Columbia
Persons With AIDS Society. The survey addressed the experience of physical and mental
impairments, and the experience and level of activity limitations and participation restrictions.
Associations were measured in three ways: 1) impact of types of impairment on social restriction;
2) impact of specific limitations on social restriction; and 3) independent association of overall
impairments and limitations on restriction levels. Logistic regression was used to measure
associations with social restriction, while ordinal logistic regression was used to measure
associations with a three-category measure of restriction level.
Results: The survey was returned by 762 (50.5%) of the BCPWA participants. Over ninety percent
of the population experienced one or more impairments, with one-third reporting over ten.
Prevalence of activity limitations and participation restrictions was 80.4% and 93.2%, respectively.
The presence of social restrictions was most closely associated with mental function impairments
(OR: 7.0 for impairment vs. no impairment; 95% CI: 4.7 – 10.4). All limitations were associated with
social restriction. Among those with ≤ 200 CD4 cells/mm3, odds of being at a higher restriction
level were lower among those on antiretrovirals (OR: 0.3 for antiretrovirals vs. no antiretrovirals;
95% CI: 0.1–0.9), while odds of higher restriction were increased with higher limitation (OR: 3.6
for limitation score of 1–5 vs. no limitation, 95%CI: 0.9–14.2; OR: 24.7 for limitation score > 5 vs.
no limitation, 95%CI: 4.9–125.0). Among those with > 200 CD4 cells/mm3, the odds of higher
restriction were increased with higher limitation (OR: 2.7 for limitation score of 1–5 vs. no
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limitation, 95%CI: 1.4–5.1; OR: 8.6 for limitation score > 5 vs. no limitation, 95%CI: 3.9–18.8), as
well as by additional number of impairments (OR:1.2 for every additional impairment; 95% CI:1.1–
1.3).
Conclusions: This population-based sample of people living with HIV has been experiencing
extremely high rates of impairments, activity limitations and participation restrictions.
Furthermore, the complex inter-relationships identified amongst the levels reveal lessons for
programming, policy and research in terms of the factors that contribute most to a higher quality
of life.
Background
For most people who are able to access and tolerate highly
active antiretroviral therapy (HAART), HIV/AIDS has
become a chronic condition characterized by cycles of ill-
ness and wellness. People live longer lives, but with phys-
ical, psychological and social challenges that affect quality
of life [1-3]. Evidence of this phenomenon may be found
in qualitative studies describing the ways in which
improved health has also brought about different and
unforeseen social, psychological and physical challenges
for many people who had previously been facing end-
stage disease.
For instance, Brashers et al (1999) identified four catego-
ries of "uncertainties" resulting from the experience of
"revival" brought about by HAART, including (a) renego-
tiating feelings of hope and future orientation in the face
of questionable durability of immune restoration; (b) fear
about social roles and identities, in the transition from a
person who is dying to a person living with a chronic ill-
ness; (c) concerns with interpersonal relations, including
the potential of stigmatizing reactions from employers
and co-workers; and, (d) reconsidering the quality of their
lives, captured in this quote from one participant, 'The
good news is you're going to live, the bad news is you're
not going to enjoy the rest of your life' [1].
Sowell et al. (1998) used in-depth interviews to explore
the psychological changes and care delivery issues experi-
enced by HIV-positive men who were facing end-stage dis-
ease but had experienced dramatic physical
improvements [4]. Key findings included themes around
protease inhibitors as a reprieve from death, shifting per-
spectives on roles and relationships, and a renewed need
for advocacy related to care, treatment and support. Oth-
ers have examined particular aspects of living with HIV in
the post-HAART era, such as challenges related to income
and employment [5]. Along with qualitative literature, the
HIV communities themselves have responded with a wave
of community-based studies, publications and program-
ming to address challenges related to living with the ups
and downs of life on combination therapies [6-9].
Quantitative studies exploring the life-and health-related
consequences of living with HIV are limited. An exception
is the HIV Cost and Services Utilization Survey in the
United States, which described physical and social role
restrictions in a nationally representative sample [10];
however, no similar work exists in Canada. The American
study was undertaken during the early years of HAART,
and so the majority of participants were not yet on pro-
tease inhibitors. As such, there is a gap in the literature in
terms of studies that systematically quantify the preva-
lence of life-and health-related challenges associated with
living with HIV since the advent of HAART.
The International Classification of Functioning, Disability
and Health (WHO, 2001) offers a useful framework for
studying disablement and health-related consequences of
disease based on the following three concepts: impair-
ments, activity limitations and participation restrictions
[11]. Impairments are understood to be problems with
physiological functioning or anatomical (e.g., organs,
limbs) structure of the body. Activity limitations are
defined as difficulties in executing a task or action. Finally,
participation restrictions are problems relating to involve-
ment in life situations. This classification system and its
precursor, the International Classification of Impair-
ments, Disabilities and Handicaps (WHO, 1980), have
been used to frame a plethora of studies on a diverse array
of diseases and conditions [12-15]. Furthermore, this
framework has been used to conceptualize HIV [16], and
informs the policy, research and advocacy work of organ-
izations such as the Canadian Working Group on HIV and
Rehabilitation [17].
This article addresses this gap in the literature by reporting
on the results of a quantitative investigation into the prev-
alence of and associations among impairments, activity
limitations and participation restrictions experienced by
people living with HIV in British Columbia.
Methods
Data sources
Individuals living with HIV were involved in all stages of
this project, from identification of the research question
to data collection and analysis. A lead partner was theHealth and Quality of Life Outcomes 2004, 2:46 http://www.hqlo.com/content/2/1/46
Page 3 of 10
(page number not for citation purposes)
British Columbia Persons With AIDS Society (BCPWA),
an organization of more than 3,600 HIV positive individ-
uals living in British Columbia, which was created to pro-
vide support, information and advocacy for its members.
From May to September of 2002, the BCPWA in conjunc-
tion with the British Columbia Centre for Excellence in
HIV/AIDS conducted a survey of HIV positive individuals
living in British Columbia. The anonymous self-adminis-
tered questionnaire was mailed to the 1508 HIV positive
individuals registered with the BCPWA who had con-
sented to receive mailings.
Definition of disability
A section of the survey on diagnosed conditions asked
participants to indicate if a doctor had ever in their life-
time diagnosed them with any conditions from a list of
thirteen, including depression, schizophrenia, bipolar dis-
order and post-traumatic stress disorder, as well as a space
to indicate any diagnoses that was not present in the list.
Participants identified their experiences during the past
month using check-lists of impairments, activity limita-
tions and participation restrictions that included space to
identify unlisted items.
Participants were asked: "Within the last month have you
experienced any of the following..." after which they were
able to check off symptoms from a list of twenty-two,
including a space for unlisted items. The list of impair-
ments was categorized into mental, internal system, sen-
sory and neuromusculoskeletal groups based on the
International Classification of Functioning, Disability and
Health [12]. Mental impairments included reduced
libido, poor concentration, poor appetite, chronic fatigue,
decreased endurance, decreased memory, impaired cogni-
tion and aphasia. Internal impairments included
diarrhea, gastric reflux, shortness of breath, constipation,
wasting, weakness, vomiting and incontinence. Sensory
impairments included headaches, altered sensations, nau-
sea, mouth pain and decreased vision. Neuromuscu-
loskeletal impairments included altered muscle tone, stiff
joints, seizures, hemiparesis and paraparesis. This section
was followed by a question which asked participants how
much HIV-related pain they had experienced in the past
month, with categorical options including none, a little
bit, mild or infrequent, moderate, severe or persistent and
don't know. Participants were also asked to pinpoint the
location(s) of their HIV related pain.
Activity limitations were addressed by asking the partici-
pants " [h]ow well can you manage these typical daily
activities?" with an indication to circle the response which
best describes their experience in the past month. A fif-
teen-item list including ability to walk one block, eat,
shower, and dress followed. For each item, participants
indicated whether they were (a) completely able, (b)
somewhat limited or (c) unable to perform the activity.
Overall prevalence of activity limitations was calculated
by including anyone indicating (b) or (c) for any one of
the fifteen items.
In the same way, participants were asked " [h]as your
health limited your usual [role/participation]" in any of a
number of categorical activities and functions. Partici-
pants were indicated to choose the response that came
closest to the way they had been feeling during the past
month. A ten-item list was used to assess levels of restric-
tion in social, student, and cultural roles. Participants
indicated whether they were (a) not limited, (b) some-
what limited or (c) very limited with respect to their abil-
ity to function in these roles. Overall prevalence of
participation restrictions was calculated by including any-
one indicating (b) or (c) for any one of the ten items.
Statistical analysis
Rates of impairments, activity limitations and participa-
tion restrictions among the participants were compared
across three categories of CD4 cell counts (≤ 200 cells/
mm3, 201 to 500 cells/mm3 and > 500 cells/mm3) using
a chi-squared test for categorical variables and the
Kruskal-Wallis test for continuous variables. Bonferroni
corrections for multiple comparisons were done for each
item and those which remained significant are indicated
in bold.
To test the hypothesis that social role restrictions would
be more strongly associated with mental function impair-
ments and personal care and mobility limitations, a series
of logistic regression models were tested with each cate-
gory of impairment and limitation. A dichotomous out-
come was used, collapsing "somewhat" and "very much"
social role restriction into any social restriction. Likewise,
specific activity limitations were dichotomized into "no
limitations" vs. "some effort" required or "unable" to
accomplish the activity. Associations of social restriction
with impairment categories and specific activity limita-
tions were examined univariately and in adjusted models
accounting for age, sex, income, depression, pain, risk cat-
egory (men who have sex with men, injecting drug users,
heterosexual contact, combination) and number of symp-
toms for activity limitation models.
A scoring system was then used to develop categories of
activity limitation and participation restriction. If a partic-
ipant indicated an activity limitation item at the highest
level ("unable" to accomplish) or a participatory role
restriction at the highest level ("very much" restricted),
two points were received, while participants indicating an
activity limitation item at moderate level (requiringHealth and Quality of Life Outcomes 2004, 2:46 http://www.hqlo.com/content/2/1/46
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"effort" to accomplish) or a participation restriction item
at a moderate level ("somewhat" restricted), one point
was received. Overall scores for participation restriction
and activity limitation were therefore dependent on both
the severity and total number of challenges in activities or
participatory roles.
The participation restriction score, with an overall maxi-
mum of 20, was then categorized into three levels: 0 to 5
points, 6 to 10 points and > 10 points, based on the pop-
ulation distribution of the score. Likewise, the activity
limitation score, with an overall maximum of 28, was also
categorized based on distribution as follows: 0, 1 to 5
points, and > 5 points. The higher the score, the greater
the disablement.
An overall model examined the associations of increasing
participation restriction level with number of impair-
ments and activity limitation scores, testing the hypothe-
sis that impairments may account for some of the
associations seen between activity limitations and partici-
pation restrictions, but that both of the former would
have independent associations with the latter. Ordinal
logistic regression was implemented, using the three-level
participation restriction outcome and testing number of
symptoms, categorical limited activity score, pain and
mental diagnoses as explanatory variables. All models
were stratified on CD4 levels, with separate models built
for individuals with counts below 200 cells/mm3, and
adjusted for age, gender, employment, years since diagno-
sis and risk category.
Results
Population characteristics
Of the 762 people living with HIV who completed the sur-
vey, 614 provided information about their CD4 levels and
were included in this analysis. The population answering
the BCPWA survey was comprised mainly of white
(88.7%), sexual-minority males (76.6%) between the
ages of 30 to 49 (63.9%). The 148 respondents who were
not included in the analysis because they did not provide
CD4 information were in a lower income bracket (42.5%
vs 19.9%; p-value < 0.001), were more likely to be current
IDUs (11.3% vs 4.3%; p-value < 0.001) and more likely to
be First Nations/Inuit/Metis (17.6% vs. 6.5%; p-value <
0.001).
A comparison of all BCPWA members who received the
survey and the subset who responded found a similar dis-
tribution of age and a similar proportion identifying as
Aboriginal (7.1% vs. 8.7%). The proportion of females
was higher among the total BCPWA population than
among the subset of respondents (13.5% vs.10.2%; p =
0.001).
Prevalence of impairments, activity limitations and 
participation restrictions
Table 1 describes levels of diagnoses, impairments, activ-
ity limitations and participation restrictions among par-
ticipants. Mental health diagnoses were reported by
62.9% (N = 479) of the participants. The most prevalent
diagnosis was depression with an overall prevalence of
58.1%. Among those listing one or more diagnoses,
92.5% experienced depression as one of their diagnoses.
While the overall number of participants with depression
appeared lower among those with CD4 ≤ 200 cells/ml, the
percent of those listing depression out of those with any
diagnosis remained close to 92.5% across all strata.
The presence of multiple impairments among the partici-
pants was also high, with a median of 7 (3,12) impair-
ments and approximately one third of the participants
experiencing more than ten impairments. At least one
impairment was reported by 91.5% (N = 697). There was
a significant difference in the distribution of impairments
across CD4 categories, which remained after Bonferroni
correction (CD4 ≤ 200 cells/ml vs CD4 > 500 cells/ml, p-
value= 0.002; CD4 ≤ 200 cells/ml vs CD4 between 200
and 500 cells/ml, p-value = 0.017). Mental impairment
was reported by 78.2% (N = 596), sensory impairment by
71.9% (N = 548), neuromuscular impairment by 49.5%
(N = 377), and internal impairment by 81.0% (N = 617)
of the participants.
Pain was reported by over half of the participants, and by
over three quarters of the participants with CD4 ≤ 200
cells/ml. Approximately one-third reported little or mild
pain and 37.1% reported moderate or severe pain. For
participants with lower CD4 counts, more people
reported moderate and severe pain (50.4% vs. 38.7% vs.
34.9%; p-value 0.08), although comparisons of each CD4
category to the others showed no significant differences.
Activity limitations were reported by 80.6% (N = 607) of
the participants. The median number of activity limita-
tions reported by an individual was 3 (1, 7). Six hundred
and ninety-nine individuals (93.2%) reported some level
of participation restriction. The median number of partic-
ipatory roles in which individuals felt somewhat or highly
restricted was 7 (3, 9). Although distributions of activity
limitations and participation restrictions were signifi-
cantly different, adjustment for multiple comparisons
across the CD4 categories resulted in no significant differ-
ence in prevalence.
Figures 1,2,3 summarize the prevalence of impairments,
activity limitations and participation restrictions, respec-
tively. The most prevalent impairments experienced by
participants included diarrhea (57.1%), reduced libido
(55.8%), general weakness (48.2%), poor concentrationHealth and Quality of Life Outcomes 2004, 2:46 http://www.hqlo.com/content/2/1/46
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(47.0%), headaches (46.9%) and chronic fatigue
(46.6%). Vigorous and moderate activities, sexual activi-
ties and household chores were the most frequently
reported limitations. The level of participation restrictions
was high for all CD4 categories, with sexual roles, student/
employee roles and financial roles being the most
prevalent.
Univariate associations of impairments and activity 
limitations on social role restrictions
Table 2 describes the univariate odds ratios for presence of
social role restriction (yes vs. no) based on impairment
categories and type of activity limitation. All impairments
and activity limitations were significantly associated with
social role restriction. Social role restriction was most
strongly associated with limitations in using the toilet,
(OR: 18.5 for toilet difficulties vs. no toilet difficulties;
95%CI: 4.5 – 76.3), followed by banking, (OR: 11.3 for
banking difficulties vs. no banking difficulties; 95%CI: 5.4
– 23.5). Social role restriction had the weakest association
with getting out of bed, (OR: 3.6 for difficulties getting out
of bed vs. no difficulties; 95%CI: 2.3 – 5.6). With respect
to impairment categories, social role restriction was most
strongly associated with mental impairments (OR 7.0 for
mental impairments vs. no mental impairments; 95% CI
4.7–10.4) although the other three impairment categories
had odds ratios higher than four.
Adjusted odds ratios stratified by CD4 counts remained
significant for getting groceries, doing laundry, household
chores, and mental functioning, regardless of CD4 levels,
although the estimates were higher for participants with
counts under 200 cells/mm3. For those with CD4 counts
above 200 cells/mm3, difficulties with eating, public
transportation, moderate or vigorous activities, sexual
activities, neuromuscular functioning and sensory func-
tioning also remained significantly associated with social
restrictions. Adjusted odds ratios for using the toilet and
getting dressed were unable to be estimated as these were
Table 1: Prevalence of diagnosed conditions, impairments and pain, activity limitations and participation restrictions experienced by 
BCPWA participants by CD4 cell counts
CD4 < 200 CD4 201 to 500 CD4 > 500 p-value
Diagnosed conditions
Depression 64 (52.0) 183 (59.2) 110 (61.5) 0.238
General Anxiety 11 (8.9) 34 (11.0) 14 (7.8) 0.488
Post traumatic Stress 6 (4.9) 18 (5.8) 13 (7.3) 0.677
Panic Disorder 8 (6.5) 35 (11.4) 12 (6.7) 0.124
Median number of impairments (IQR) 9 (5, 13) 7 (2.5, 12) 7 (3, 12) 0.006
% With any impairment 120 (97.6) 285 (92.5) 161 (89.9) 0.041
Pain
None 25 (20.7) 82 (29.4) 48 (28.4) 0.079
Little/mild 35 (28.9) 89 (31.9) 62 (36.7)
Moderate/severe 61 (50.4) 108 (38.7) 59 (34.9)
Median number of activity limitations (IQR) 3 (1, 7) 3 (1, 7) 2 (1, 5) 0.015
% With any Activity Limitation 108 (87.8) 236 (77.4) 137 (76.5) 0.031
Median number of Participation Restrictions (IQR) 7 (4, 9) 7 (3, 9) 7 (3, 9) 0.251
% With any Participation Restrictions 121 (98.4) 278 (91.5) 161 (89.9) 0.017
Bold print indicates comparison that remained significant at the p = 0.016 level after Bonferroni correction for multiple comparisons.
Prevalence of specific impairments for participants with CD4  counts ≤ 200 cells/mm3 (speckled bars), 201 to 500 cells/ mm3 (downward diagonally-striped bars) and > 500 cells/ mm3 (horizontally-striped bars) Figure 1
Prevalence of specific impairments for participants with CD4 
counts ≤ 200 cells/mm3 (speckled bars), 201 to 500 cells/
mm3 (downward diagonally-striped bars) and > 500 cells/
mm3 (horizontally-striped bars). Significant p-value from chi-
square test across CD4 categories.
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co-linear with the outcome. Stratified, unadjusted esti-
mates of 9-fold and 37-fold increases in social restriction
were seen with limitations in toileting.
Stratification by CD4 levels indicated a general effect
modification across activity limitations and impairment
categories, with greater, although more unstable, associa-
tions with social restrictions being found among partici-
pants with < 200 cells/mm3.
Multivariate associations of impairments and activity 
limitations with participation restriction levels
Table 3 describes the ordinal logistic regression model
examining associations with a three-category measure of
participation restriction level, stratified by CD4 cell
counts. Among those with CD4 counts under 200 cells/
mm3, being in a higher category of participation
restriction was strongly associated with having activity
limitation scores above ten, and was marginally inversely
associated with being on antiretrovirals. Increasing
number of impairments did not show any significant
association.
Among participants with CD4 counts above 200 cells/
mm3, being in a higher category of participation restric-
tion was associated with increasing levels of limited activ-
ity [(OR: 2.7 for limited activity scores of 4–10 vs. scores
< 4; 95%CI: 1.4–5.1) and (OR: 8.6 for limited activity
scores > 10 vs. scores < 4; 95%CI: 3.9–18.8)]. A higher
participation restriction category was also significantly
associated with increasing number of impairments, with a
19% increase in the odds with additional impairment.
Increased participation restriction level was only margin-
ally significantly associated with moderate or severe pain;
however, point estimates for the pain categories suggested
a dose response relationship, as did the inclusion of pain
as a continuous variable (p-value 0.066).
Discussion
This study has demonstrated that a population-based
sample of people living with HIV in British Columbia
have been experiencing strikingly high levels of depres-
sion, body impairments, activity limitations and partici-
pation restrictions. The latter two categories were higher
among this population than a national survey of HIV pos-
itive persons in the United States[10]. However, the Amer-
ican study was conducted prior to HAART availability,
underscoring the importance of examining quality of life
issues faced in the post-HAART era. In a study examining
similar concepts of activity limitation among cancer
patients, the percent experiencing any difficulties ranged
Prevalence of specific activity limitations for participants with  CD4 counts ≤ 200 cells/mm3 (speckled bars), 201 to 500  cells/mm3 (downward diagonally-striped bars) and > 500  cells/mm3 (horizontally-striped bars) Figure 2
Prevalence of specific activity limitations for participants with 
CD4 counts ≤ 200 cells/mm3 (speckled bars), 201 to 500 
cells/mm3 (downward diagonally-striped bars) and > 500 
cells/mm3 (horizontally-striped bars). Significant p-value from 
chi-square test across CD4 categories.
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Prevalence of specific participation restrictions for partici- pants with CD4 counts ≤ 200 cells/mm3 (speckled bars), 201  to 500 cells/mm3 (downward diagonally-striped bars) and >  500 cells/mm3 (horizontally-striped bars) Figure 3
Prevalence of specific participation restrictions for partici-
pants with CD4 counts ≤ 200 cells/mm3 (speckled bars), 201 
to 500 cells/mm3 (downward diagonally-striped bars) and > 
500 cells/mm3 (horizontally-striped bars). Significant p-value 
from chi-square test across CD4 categories.
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from 18.0 to 70.0%, depending on the type of cancer, but
was only 30.0% overall [18]. Another study of cancer sur-
vivors found a similar prevalence to that seen in the
present study (80.0%) when including all ambulatory dif-
ficulties, not just activities of daily living [19]. The
elevated levels of limitation among the BCPWA popula-
tion were also emphasized in a comparison with the gen-
eral population and with those identifying as suffering
from a chronic illness, where the least difference showed
a five-fold increase [20].
The level of depression among this population was
extremely high. Nearly 60.0% of the participants reported
ever having been diagnosed with depression by a doctor.
Levels of depression among HIV positive persons reported
in the literature range from 5.0% to 40.0%, although
among HIV positive women, 60.0% prevalence has been
reported [21,22]. Depression is generally found to be
higher, regardless of HIV status, among women and men
who have sex with men [21]. Studies conducted among
MSM have found prevalence of major depression to range
from 23.0 to 37.0%, while Aboriginal populations in gen-
eral, and Aboriginal MSM in particular, have been shown
to have higher depression scores [23-25]. Likewise,
depression among IDU populations has been seen to be
as high as 47.0% [24]. Some study scales may capture
current depression but may miss the experience of people
with recurrent episodes who feel well at the time of test-
ing. The high level of depression recorded in this study
may be the result of a large percentage of men who have
sex with men in the sample as well as the survey's ability
to capture more cumulative measures of depression. The
high prevalence may be due in part to the self-report of the
diagnosis as well, which may result in recall bias and
increased reporting of non-diagnosed depression. Regard-
less, this common experience of depression demands con-
sideration by researchers, policy-makers and care
providers concerned with the quality of life of people liv-
ing with HIV.
The prevalence of impairments was also high, with
diarrhea at the top of the list, followed by problems with
fatigue and endurance. Furthermore, challenges with
daily activities and social roles were extremely common,
at greater than 80.0 and 90.0%, respectively. The high pro-
portion of individuals experiencing impairments, activity
limitations and participation restrictions sheds light on
the spectrum of challenges related to living with HIV.
Even among those with relatively high CD4 counts, the
impact of HIV on disability and health is not trivial.
Table 2: Univariate and adjusted odds ratios for social role restriction given each activity limitation and prevalence of these limitations 
in this population
Activity Prevalence (%) Odds Ratio (95% CI) Adjusted Odds Ratio (95% CI)*
≤ 200 cells/ml > 200 cells/ml
Getting dressed 8.9 (54) 4.03 (2.03 – 8.00) 7.90** (0.45 – 137) 1.60 (0.47 – 5.44)
Using the toilet 6.3 (38) 18.47 (4.47 – 76.3) 9.14** (0.52 – 159) 37.7** (2.29 – 620)
Showering 10.2 (62) 6.62 (3.15 – 13.91) 3.38 (0.41 – 28) 2.30 (0.57 – 9.18)
Walking one block 13.2 (80) 5.33 (2.86 – 9.91) 3.33 (0.54 – 20) 3.40 (0.72 – 16)
Banking 16.4 (99) 11.27 (5.42 – 23.45) 3.78 (0.33 – 42) 3.30 (1.09 – 10)
Getting out of bed 20.8 (125) 3.63 (2.34 – 5.63) 1.15 (0.31 – 4.14) 1.89 (0.79 – 4.54)
Driving 21.5 (121) 3.51 (2.25 – 5.47) 1.59 (0.45 – 5.49) 1.93 (0.87 – 4.31)
Eating 20.1 (122) 4.66 (2.89 – 7.53) 0.87 (0.26 – 2.94) 3.17 (1.07 – 9.37)
Public Transportation 25.2 (148) 6.75 (4.19 – 10.86) 4.36 (0.91 – 21) 3.29 (1.32 – 8.20)
Laundry 28.1 (171) 7.53 (4.73 – 11.98) 8.41 (1.32 – 54) 3.26 (1.41 – 7.52)
Groceries 32.6 (198) 8.43 (5.38 – 13.21) 3.97 (1.21 – 13) 2.97 (1.37 – 6.43)
Household chores 39.6 (241) 6.89 (4.72 – 10.06) 5.12 (1.62 – 16.2) 3.11 (1.59 – 6.10)
Moderate activity 42.4 (258) 5.87 (4.11 – 8.37) 2.10 (0.76 – 5.77) 3.10 (1.62 – 5.93)
Sexual activity 46.6 (283) 5.33 (3.81 – 7.47) 2.56 (1.00 – 6.57) 2.06 (1.16 – 3.68)
Vigorous activity 71.9 (437) 5.09 (3.61 – 7.19) 2.69 (0.97 – 7.48) 2.60 (1.37 – 4.96)
Impairment Category
Mental functioning 78.7 (481) 7.02 (4.73 – 10.4) 18.71 (2.31 – 151) 4.32 (2.20 – 8.51)
Neuro-musculoskeletal functioning 49.3 (301) 4.12 (2.98 – 5.69) 1.77 (0.67 – 4.68) 1.76 (1.03 – 3.00)
Sensory functioning 72.3 (442) 4.12 (2.94 – 5.78) 0.85 (0.27 – 2.65) 2.17 (1.20 – 3.93)
Internal functioning 81.4 (500) 4.15 (2.82 – 6.12) 2.48 (0.69 – 8.91) 1.84 (0.96 – 3.51)
*Adjusted for age, gender, income, number of impairments (for activity limitation models), pain, risk category and doctor-diagnosed depression
**Small sample size; analysis stratified on CD4 but not adjusted due to zero cells.Health and Quality of Life Outcomes 2004, 2:46 http://www.hqlo.com/content/2/1/46
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Of note, the differences experienced between people
according to categories of CD4 levels were less and less
apparent going from impairments (problems at the level
of organ or body part) to activity limitations to participa-
tion restrictions (problems with social roles). This draws
attention to the variety of influences affecting a person's
ability to perform daily tasks and participate in regular
societal roles above and beyond his/her clinical measures
of disease status.
All types of activity limitation were associated with the
experiencing of social role restrictions. After accounting
for impairments, depression and pain levels, there
remained significant associations between household
upkeep, including laundry and groceries, and social role
participation. Although it was hypothesized that personal
care issues would have stronger associations, this was not
the case. This may be because the severity of personal care
limitations (dressing, eating, showering) is such that
among those experiencing these limitations, the presence
of pain or numerous impairments overshadows any inde-
pendent association between the limitation and social
restriction.
Household chores, getting groceries and doing laundry as
well as moderate and vigorous activities had significant
associations with social role restrictions and had the high-
est prevalence in this population. Therefore, interventions
that target these types of limitations may provide the most
benefit at a population level. Whether or not these inter-
ventions would have any impact on an individual's feel-
ings of participatory restriction remains to be seen;
however, coordinating these types of simple interventions
might offer contact with people in need of social support.
Mental impairments were the most prevalent of the four
impairment categories and were found to have a signifi-
cant association with participation restrictions. These
results mirror a study describing disability among a
national sample of people living with HIV in the United
States which reported a correlation between general
fatigue and increased limitations in both physical and role
functions [10]. Other reports have also found relation-
ships among neuropsychological performance, depres-
sion, stress levels and perceived disability [26]. It is
suggested that increased social support networks can
result in improved mental health, which may indicate that
the association between the presence of mental impair-
ment and the ability to interact in social and community
roles is not unidirectional.
The adjusted models (Table 3) indicate that both impair-
ments and activity limitations remain associated with par-
ticipation restrictions independent of one another for
people with high CD4 counts. The use of antiretrovirals
among those with low CD4 counts is associated with
lower participation restriction levels. Since this cannot be
accounted for through a lessening of impairments or lim-
itations among those on antiretrovirals, it is more likely a
reflection of the type of support and interaction with the
health care system among those who are able to access
antiretrovirals.
Limitations of the study
Limitations of the study include the somewhat homoge-
neous nature of the participants, which affects the gener-
alizability of these findings to other populations. The
participants were mainly white, sexual-minority males
with moderate yearly incomes and stable housing. The
under-representation of people who are homeless, injec-
tion drug users, female and Aboriginals becomes apparent
when comparing the low proportions seen amongst the
BCPWA membership to the higher proportions seen in
incident cases reported by the British Columbia Centre for
Disease Control [27].
Table 3: Ordinal logistic regression estimating the probability of 
being in a higher category of the three level participation 
restriction score based on levels of impairment, limited activity 
scores and pain.
CD4 ≤ 200
OR* 95% CI
Limited Activity score
None 1
1–5 3.58 0.91 – 14.2
> 5 24.7 4.85 – 125
Number of impairments 1.01 0.94 – 1.12
Antiretroviral use 0.28 0.08 – 0.93
CD4 > 200
OR* 95% CI
Limited Activity score
None 1
1–5 2.67 1.40 – 5.12
> 5 8.56 3.90 – 18.8
Number of impairments 1.19 1.12 – 1.25
Pain
None 1
Some/mild 1.31 0.71 – 2.44
Mod/severe 1.78 0.85 – 3.75
Antiretroviral use 1.39 0.83 – 2.35
*adjusted for age, gender, employment, education, years since 
diagnosis and risk categoryHealth and Quality of Life Outcomes 2004, 2:46 http://www.hqlo.com/content/2/1/46
Page 9 of 10
(page number not for citation purposes)
The survey was sent to BCPWA members consenting to
receive mail. Individuals who did not consent were more
likely to reside in the Greater Vancouver region, suggest-
ing a greater geographical representation from outside of
this urban area. Non-consenting BCPWA members were
also more likely to be female (15.8% vs 11.9%) and more
likely to be First Nations, Inuit or Metis (27.1% vs 8.4%).
Furthermore, because the survey was anonymous and self-
reported, there are issues with missing data and
incomplete records. For example, almost 20.0% of the
sample, again representing a high proportion of women
and First Nations, were excluded because of missing CD4
information. While the exclusion of this population may
have affected the power and generalizability of the study,
one may argue that challenges reported in this study may
be an underestimation of the restrictions in this popula-
tion due to compounding social inequity issues.
Lastly, there are limitations in the nature of self-reported
diagnoses. Participants may have trouble recalling the
presence or absence of impairments, limitations or restric-
tions over the past month. Although there was no direct
incentive, participants may be biased towards increased
reporting of problems as they may feel that this would be
beneficial for program funding and support.
Despite these limitations, this survey represents a large
provincial sample and is one of few attempts to collect
information from a population-based sample on this
scale. Furthermore, this is one of the first studies to sys-
tematically quantify levels of disablement among persons
living with HIV.
Conclusions
This study revealed a strikingly high prevalence of impair-
ments, activity limitations and participation restrictions
among a population-based sample of people living with
HIV in British Columbia. The complicated interplay
among these categories requires further study, but it is
clear that interventions designed to help overcome activ-
ity limitations and social support programs are required,
especially those addressing mental impairments and
depression. While impairments and limitations are not
always reversible, innovative programs that help people
living with HIV address these challenges may help to
decrease the subsequent high rates of participatory
restrictions experienced. Antiretroviral treatments have
enabled the prolongation of the lives of people who are
HIV-infected; now we need to give due attention to opti-
mizing the quality of these extended lives.
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